114719-57-2
114719-57-2
Chemical Structure
Fascaplysin
- CAS No.: 114719-57-2
- Formula:C18H11ClN2O
- Molecular Weight:306.75
IUPAC Name: 13-oxo-12,13-dihydropyrido[1,2-a:3,4-b']diindol-5-ium chloride
InChIKey: PWUOOJVYZQILBG-UHFFFAOYSA-N
SMILES: O=C1C2=C3NC4=C(C=CC=C4)C3=CC=[N+]2C5=C1C=CC=C5.[Cl-]
Biological Activity: Fascaplysin is an antimicrobial and cytotoxic red pigment, that can come from the marine sponge (Fascaplysinopsis sp.). Fascaplysin has been synthesized in seven steps from indole (65% yield). Fascaplysin can induces apoptosis and autophagy in human leukemia HL-60 cells. Fascaplysin shows anti-tumor activity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fascaplysin | 95.64% | Fascaplysin is an antimicrobial and cytotoxic red pigment, that can come from the marine sponge (Fascaplysinopsis sp.). Fascaplysin has been synthesized in seven steps from indole (65% yield). Fascaplysin can induces apoptosis and autophagy in human leukemia HL-60 cells. Fascaplysin shows anti-tumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.83
HY-144822Anti-MRSA agent 2 -
Similarity Score 0.67
HY-144823Anti-MRSA agent 3 -
Similarity Score 0.51
HY-N6607RTryptanthrin (Standard) -
Similarity Score 0.51
HY-115908ZDLD13 -
Similarity Score 0.51
HY-12451FICZ -
Similarity Score 0.51
HY-162108Antitumor agent-128 -
Similarity Score 0.50
HY-N6736K-252c -
Similarity Score 0.50
HY-156843Antiproliferative agent-38 -
Similarity Score 0.49
HY-103382RArcyriaflavin A (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. BenjaminPelcman, Gordon WGribble. Total synthesis of the marine sponge pigment fascaplysin. Tetrahedron Letters. 1990, 31(17):2381-2384.
- [2]. Zhidkov ME, et al. Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues. Mar Drugs. 2019 Aug 25;17(9):496. [Content Brief]
